Olfactory sensations contribute to sexual desire and sexual behavior. However, the degree to which individual importance of olfactory function and body odors relate to sexual desire is not known. This study was conducted to preliminarily examine these relationships among Chinese college students (N = 1903) via the Importance of Olfaction Questionnaire, the Body Odor Sniffing Questionnaire, and the Sexual Desire Inventory, which were used to measure subjective significance of olfaction, frequency of sniffing self or others, and sexual desire, respectively. Individuals who assigned higher importance to olfaction or engaged more in body odor sniffing showed stronger sexual desire. We further explored these associations in different cultures to determine whether cultural consistency existed. We conducted a second study to make cross-cultural comparisons between Indian (N = 313) and US (N = 249) populations. For both countries, a higher importance placed on olfaction and a higher prevalence of body odor sniffing were consistently associated with stronger sexual desire. In conclusion, our study confirmed that people who placed more value on olfactory function or engaged more in body odor sniffing showed stronger sexual desire. These correlations were consistent for both sexes and across different cultures, further indicating the importance of olfaction in sexuality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10508-022-02398-1 | DOI Listing |
Turk Arch Pediatr
January 2025
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Guwahati, Assam, India.
Objective: The personal experiences of breastfeeding healthcare workers may influence the quality of breastfeeding support provided. This study explored the breastfeeding experiences of nurses and support staff in South India. Materials and Methods: A qualitative exploratory study using focus group discussions (FGDs) was conducted among nurses and support staff of a newly established tertiary care hospital in South India.
View Article and Find Full Text PDFContraception
January 2025
Bill & Melinda Gates Foundation, 500 5th Avenue N, Seattle, WA, 98109, USA.
Objective: To evaluate construct validity of the contraception-focused "Preference-aligned Fertility Management" (PFM) Index, a new person-centered and rights-based outcome measure, in Nigeria and Uganda.
Study Design: We analyzed survey data from convenience samples of new users of contraception and non-users of contraception in Uganda and users of contraception in Nigeria. PFM Index scores were calculated by combining two indicators: Indicator 1 assessing alignment between desire to use contraception and actual use; Indicator 2 evaluating whether users' current methods are desired.
Int J Mol Sci
December 2024
2nd Department of Obstetric and Ginecology, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania.
Endometriosis, a chronic hormone-dependent condition affecting 10% of women globally, impacts pelvic organs and occasionally distant sites, causing pain, infertility, and sexual dysfunction. Biomarkers such as IL-8, IL-10, and BDNF influence inflammation, nerve sensitization, and pain. This study investigates their relationship with sexual quality of life, focusing on dyspareunia and related dysfunctions, as assessed using the Female Sexual Function Index (FSFI).
View Article and Find Full Text PDFBMC Womens Health
January 2025
Department of Public Health, Khoy University of Medical Sciences, Khoy, Iran.
Background: Sexual self-care and quality of sexual life are critical factors in women's health. These factors can also influence women's fertility desire. This study aims to examine sexual self-care, quality of sexual life, and their relationship with fertility desire in women attending comprehensive health centers in Urmia.
View Article and Find Full Text PDFNeuropharmacology
January 2025
Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Hypoactive sexual desire disorder (HSDD) is the most reported sexual dysfunction among premenopausal women worldwide. Bremelanotide, trade name Vyleesi, has been approved by the United States Food and Drug Administration to treat HSDD. However, despite approval, very little is known about its neurobiological mechanism of action.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!